References
- Kema IP, de Vries EG, Muskiet FA. Clinical chemistry of serotonin and metabolites. J Chromatogr B Biomed Sci Appl 2000;747:33–48.
- Ohkawa R, Hirowatari Y, Nakamura K, Ohkubo S, Ikeda H, Okada M, Tozuka M, Nakahara K, Yatomi Y. Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. Clin Biochem 2005;38:1023–6.
- Hirowatari Y, Hara K, Kamihata H, Iwasaka T, Takahashi H. High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. Clin Biochem 2004;37:191–7.
- Gustafsson BI, Tommeras K, Nordrum I, Loennechen JP, Brunsvik A, Solligard E, Fossmark R, Bakke I, Syversen U, Waldum H. Long-term serotonin administration induces heart valve disease in rats. Circulation 2005;111:1517–22.
- Hauso O, Gustafsson BI, Loennechen JP, Stunes AK, Nordrum I, Waldum HL. Long-term serotonin effects in the rat are prevented by terguride. Regul Pept 2007;143: 39–46.
- Hervé P LJ, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995;99:249–54.
- Maclean MR, Dempsie Y. The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med Biol 2010;661:309–22.
- Tyce GM. Origin and metabolism of serotonin. J Cardiovasc Pharmacol 1990;16(Suppl. 3):S1–7.
- de Jong WHWM, de Vries EG, Kema IP. Automated mass spectrometric analysis of urinary and plasma serotonin. Anal Bioanal Chem 2010;396:2609–16.
- Beck OWN, Bröijersén A, Larsson PT, Hjemdahl P. On the accurate determination of serotonin in human plasma. Biochem Biophys Res Commun 1993;196:260–6.
- Brand T, Anderson GM. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem 2011; 57:1376–86.
- Kaplan ZS, Jackson SP. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program 2011;2011:51–61.
- Wu JT EA, Tsao KC, Wu TL, Sun CF. Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages. Ann Clin Lab Sci 2000; 30:175–8.
- Anderson GM, Feibel FC, Cohen DJ. Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sci 1987;40:1063–70.
- Saracino MA, Gerra G, Somaini L, Colombati M, Raggi MA. Chromatographic analysis of serotonin, 5-hydroxyindolacetic acid and homovanillic acid in dried blood spots and platelet poor and rich plasma samples. J Chromatogr A 2010;1217:4808–14.
- Larsson PT, Wallen NH, Egberg N, Hjemdahl P. Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements. Clin Sci (Lond) 1992; 82:369–76.
- Hirowatari Y, Hara K, Shimura Y, Takahashi H. Serotonin levels in platelet-poor plasma and whole blood from healthy subjects. Relationship with lipid markers and coronary heart disease risk score. J Atheroscler Thromb 2011;18:874–82.
- Culafic DM MD, Vukcevic MD, Rudic JS. Plasma and platelet serotonin levels in patients with liver cirrhosis. World J Gastroenterol 2007;13:5750–3.
- Meijer WG, Kema IP, Volmer M, Willemse PH, de Vries EG. Discriminating capacity of indole markers in the diagnosis of carcinoid tumors. Clin Chem 2000;46:1588–96.
- Kema IP MW, Meiborg G, Ooms B, Willemse PH, de Vries EG. Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection. Clin Chem 2001;47:1811–20.